Pasternak O, Westin CF, Bouix S, et al. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci. 2012;32(48):17365-72. doi:10.1523/JNEUROSCI.2904-12.2012
Hartz SM, Pato CN, Medeiros H, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014;71(3):248-54. doi:10.1001/jamapsychiatry.2013.3726
Goldstein JI, Jarskog F, Hilliard C, et al. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nat Commun. 2014;5:4757. doi:10.1038/ncomms5757
Jackson J, Eaton W, Cascella N, et al. Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia. Schizophr Res. 2014;159(2-3):539-42. doi:10.1016/j.schres.2014.09.023
Agerbo E, Sullivan PF, Vilhjálmsson BJ, et al. Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysis. JAMA Psychiatry. 2015;72(7):635-41. doi:10.1001/jamapsychiatry.2015.0346
Padmanabhan JL, Nanda P, Tandon N, et al. Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. J Psychiatr Res. 2016;77:52-8. doi:10.1016/j.jpsychires.2016.02.015
Wright J. Genetics: Unravelling complexity. Nature. 2014;508(7494):S6-7. doi:10.1038/508S6a
Hill K, Buchholz A, Amsbaugh H, et al. Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment. Schizophr Res. 2015;166(1-3):310-5. doi:10.1016/j.schres.2015.05.018